Glutathione peroxidase (GPX) has a powerful role in scavenging reactive oxygen species. In previous papers we have developed a new strategy for generating abzymes : the monoclonal antibody with a substrate-binding site is first prepared, then a catalytic group is incorporated into the monoclonal antibody's binding site by using chemical mutation [Luo, Zhu, Ding, Gao, Sun, Liu, Yang and Shen (1994) [251][252][253][254][255]. Since then we have established a series of catalytic antibodies capable of catalysing the decomposition of hydroperoxides by GSH. The monoclonal antibody 2F3 was raised against GSH-S-2,4-dinitrophenyl t-butyl ester and exhibited high catalytic efficiency, exceeding that of rabbit liver GPX, after chemical mutation. To produce pharmaceutical proteins and to study the reason why it exhibits high catalytic efficiency, we sequenced, cloned and expressed the variable regions of 2F3 antibody as a single-chain Fv fragment (2F3-
INTRODUCTION
Reactive oxygen species, including the superoxide anion (O − : # ), H # O # , organic peroxides and the hydroxyl radical, are normal products of aerobic metabolism. However, they are known to destroy key biological molecules and cause damage to cell membranes [1] . Examples of such oxidative-stress-related diseases include reperfusion injury, brain ischaemia, tumour, cataract and various types of inflammation and physiological aging. Living organisms have evolved a family of antioxidant enzymes to cope with oxidative stress, including superoxide dismutase, which catalyses the dismutation of O − :
# to H # O # , the seleniumcontaining enzyme glutathione peroxidase (GPX), which catalytically destroys hydroperoxides, and catalase, which catalyses the breakdown of H # O # . The GPXs are substantially more efficient on a molar basis than the other enzymes [2] .
At least four forms of GPX have been reported so far ; they are different in many properties, including their localization, subunit structure, primary structure and enzymic nature. The classical cellular GPX (GSHPx-1), found in the cytosol of various tissues and blood cells, reduces H # O # and organic hydroperoxides but cannot reduce phospholipid hydroperoxides [3] . A second GPX, phospholipid hydroperoxide GPX, is believed to be mostly cytosolic and partly membrane-bound and reduces phospholipid hydroperoxide as well as H # O # [4] [5] [6] . A third GPX in plasma, extracellular GPX, is reported to reduce both H # O # and phospholipid hydroperoxides [7, 8] . A fourth GPX, gastrointestinal GPX, Abbreviations used : 2F3-scFv, single-chain Fv fragment of monoclonal antibody 2F3 ; GPX, glutathione peroxidase ; GSHPx-1, classical cellular GPX; IMAC, immobilized metal-affinity chromatography ; IPTG, isopropyl β-D-thiogalactoside ; N 2 ph, 2,4-dinitrophenyl ; scFv, single-chain Fv fragment ; Se-2F3-scFv, selenium-containing 2F3-scFv. 1 To whom correspondence should be addressed (e-mail gmluo!mail.jlu.edu.cn).
scFv) in different bacterial strains. The amounts of 2F3-scFv proteins expressed from JM109 (DE3), BL21 (DE3), and BL21 (coden plus) were 5-10 %, 15-20 % and 25-30 % of total bacterial proteins respectively. The 2F3-scFv was expressed as inclusion bodies, purified in the presence of 8 M urea by Co# + -immobilized metal-affinity chromatography (IMAC) and renatured to the active form in itro by gel filtration. The binding constants of the active 2F3-scFv for GSH and GSSG were 2.46i10& M −" and 1.03i10& M −" respectively, which were less by one order of magnitude than that of the intact 2F3 antibody. The active 2F3-scFv was converted into selenium-containing 2F3-scFv (Se-2F3-scFv) by chemical modification of the reactive serine ; the GPX activity of the Se-2F3-scFv was 3394 units\µmol, which approaches the activity of rabbit liver GPX.
Key words : artificial enzyme, chemical mutation, enzyme mimics, protein engineering, selenium.
is highly expressed in the mucosal epithelium of the gastrointestinal tract [9, 10] . Of these forms, GSHPx-1 has been well studied [3] . The mechanism by which GSHPx-1 catalyses the breakdown of hydroperoxides has been extensively studied (Scheme 1). The selenol of a reduced selenocysteine molecule (ESeH) is oxidized by the hydroperoxides to generate a selenenic acid (ESeOH). The tripeptide GSH then reacts with the selenenic acid, affording the corresponding water and selenenyl
Scheme 1 Mechanism by which GSHPx-1 catalyses the breakdown of hydroperoxides Figure 1 Structures of the haptens used to generate antibodies
From top left, clockwise : GSH-S-N 2 phMe, 3G5 ; GSH-S-N 2 phBu, 2F3 ; GSSGMe, 5C9 ; GSH-S-N 2 ph, 4A4. sulphide (ESeSG). A second molecule of GSH attacks the sulphur of the latter species, producing GSH disulphide and regenerating the selenol (ESeH) to complete the catalytic cycle [3] . Recently, many GPX mimics have been prepared and have been used to study antioxidant activity. In particular, the cyclic selenenamide Ebselen has been shown to be a good catalyst for the reduction of peroxides and hydroperoxides with thiol [11] . Although this interesting molecule has been researched extensively from pulse-radiolytic studies on radical reactivity through its biological properties in organs to phase III clinical trials in Japan as an antioxidant [12] [13] [14] [15] , it has some drawbacks such as its low GPX activity and its insolubility in water [12] . In addition to selenocyclodextrins [16] [17] [18] , other mimics have been well reviewed in [19] .
Complementarity between enzyme and transition state is the essence of biological catalysis, which has been used to generate catalytic antibody [20] [21] [22] . The reaction mechanism of native GPX is very complicated and proceeds through several intermediates, which have not been fully explained and therefore the transition state is not known ; thus a reasonable transition-state analogue has not been available. Using the substrate analogues GSH-S-N # ph (4A4) [23, 24] , GSH-S-N # phMe (3G5), GSSGMe (5C9) and GSH-S-N # phBu (2F3) [25] as haptens (in which N # ph represents 2,4-dinitrophenyl) (Figure 1 ), we obtained monoclonal antibodies capable of binding the substrate GSH. These monoclonal antibodies could be converted into catalytic antibodies when the selenocysteine residues were incorporated into the binding sites of the antibodies. In this way we generated several catalytic antibodies that efficiently catalysed the breakdown of hydroperoxides by GSH. Among them, several antibodies have been found to display remarkably high catalytic efficiencies, which exceed those of some of the native enzymes (Table 1) . In the present study we constructed an expression vector of 2F3-scFv, the single-chain Fv (scFv) fragment of monoclonal antibody 2F3, for the large-scale production of recombinant protein as inclusion bodies in bacteria. The refolded scFv protein was converted into selenium-containing 2F3-scFv (Se-2F3-scFv) protein and the GPX activity of the Se-2F3-scFv-catalysed reduction of H # O # by GSH approached the activity of GPX from rabbit liver.
EXPERIMENTAL Materials
Plasmids pTMF, pTHA90 and pGEM-T and Escherichia coli JM109 (DE3), BL21 (DE3) and BL21 (coden plus) were provided by Dr Hualiang Huang (Institute of Genetics, Chinese Academy of Sciences, Beijing, China). The E. coli Top10 was purchased from Invitrogen. Oligonucleotides were synthesized with an Applied Biosystems 391 DNA synthesizer and were purified on oligonucleotide purification cartridges (Applied Biosystems). Chelating Sepharose Fast Flow, Sephadex G-75 and Sephadex G-25 were purchased from Phamarcia Biotech. Ultrogel AcA44 was obtained from LKB. All other chemicals were of analytical grade and were readily available from commercial sources.
Electrophoresis and Western blotting
SDS\PAGE was run with a Pharmacia PhastSystem with 12.5 % (w\v) gels. Gels were stained with Coomassie Brilliant Blue G250. The proteins produced in the E. coli cultures were subjected to SDS\PAGE, blotted to nitrocellulose membrane and incubated with blocking buffer at room temperature for 1 h. The membrane was incubated with anti-His ' antibody and then peroxidase-conjugated goat anti-mouse IgG. Finally, peroxidase signals were measured with a 3,3h,5,5h-tetramethylbenzidine system.
Cloning of antibody variable genes
Hybridomas were prepared from mice immunized with a hapten, GSH-S-N # phBu (2F3), conjugated with BSA. Total RNA was purified from hybridomas with a Total RNA Extraction System (Promega) ; mRNA was isolated from total RNA with a PolyAT Tract System (Promega) and cDNA was generated by reversetranscriptase-mediated PCR by using Time Saver cDNA Synthesis (Promega). PCR amplification of V H and V L was performed with the light-chain primer mix (Pharmacia Biotech) for V L and the heavy-chain primer mix (Pharmacia Biotech) for V H , for 30 cycles of 94 mC for 1 min, 55 mC for 2 min and 72 mC for 1 min. This was followed by a single incubation at 72 mC for 10 min. PCR products were purified by extraction with phenol\ chloroform (25 : 24, v\v) and precipitation with ethanol, ligated to the plasmid vector pGEM-T and transformed into E. coli Top 10.
Construction of a 2F3-scFv expression vector
The plasmids containing the cloned heavy and light variable regions were used as templates for PCR with primers V L 5h (5h-CCTCTAGAGCTGTTGTGATGACCCAAACTCC-3h ; XbaI) and V L 3h (5h-CCGAATTCTTTCATTTCCAGCTTGGTCCCG3h ; EcoRI) for V L , and V H 5h (5h-GGCTCGAGCAGGTGCAG-CTGCAGCAGTCAGG-3h ; XhoI) and V H 3h (5h-GGACTAGT TGAGGAGACGGTGACCGTGGTCC-3h ; SpeI) for V H . PCR was performed with 30 cycles (denaturation at 94 mC for 1 min ; annealing at 60 mC for 1 min and extension at 72 mC for 1 min). The PCR products were isolated by agarose-gel electrophoresis and purified with a Watson gel extraction kit (Promega), then cleaved with relevant restriction enzymes (Promega) and cloned separately into pTHA90 vector. Finally, V H genes and V L genes were incorporated into the same vector and connected with a linker (Gly % Ser) $ . The resulting plasmid was designated pTHA90scFv. Colonies selected from the pTHA90scFv construct were used to confirm insert integrity by restriction-enzyme digestion and PCR analysis. DNA sequencing was then performed in the DNA Sequencing Unit of the Genecore Corporation of Shanghai by Applied Biosystems DNA sequencers with the T7 Sequencing4 kit (Pharmacia).
The pTHA90scFv construct was digested with the relevant restriction enzymes (EcoRI and XbaI) and ligated into pTMF expression vector that had been digested with the same restriction enzyme. The resulting plasmid encoding scFv was designated pTMFscFv, which was used to transform E. coli Top 10. After transformation, colonies were selected in which the pTMFscFv construct was in the correct orientation, as judged by restriction mapping and PCR analysis.
Expression of 2F3-scFv gene in E. coli
E. coli JM109 (DE3), BL21 (DE3) and BL21 (coden plus) cells were transformed with pTMFscFv containing the V H -linker-V L construct and each cultivar was grown at 37 mC to mid-exponential phase (D &*! 0.5-1.0) in Luria-Bertani medium containing kanamycin (50 µg\ml). The production of 2F3-scFv proteins was then induced by the addition of 1 mM isopropyl β--thiogalactoside (IPTG). After incubation for 8 h, the pellets from 2 ml cultures from a single colony were lysed in SDS loading buffer and subjected to SDS\PAGE. One colony that produced large amounts of protein as judged by Coomassie staining was chosen for further experiments. For the large-scale production of 2F3-scFv proteins this colony was grown and induced as described above in 500 ml. The cell pellet was washed with TE buffer [20 mM Tris\2.5 mM EDTA (pH 8.0)] and resuspended at a density of 1 g of wet bacteria per 10 ml of TE containing hen'segg lysozyme (1 mg\ml). After incubation overnight at 4 mC, cell lysis was completed by sonication in the presence of 0.5 % (v\v) Triton X-100. Inclusion bodies were pelleted at 22 000 g for 30 min and washed twice with TE buffer containing 0.5 % Triton X-100, followed by three more washes with TE buffer without Triton X-100.
Purification and refolding of 2F3-scFv from inclusion bodies
Inclusion bodies were purified by Co# + -immobilized metalaffinity chromatography (IMAC) before being refolded. In brief, inclusion bodies were resuspended in buffer TU [20 
Measurement of the binding constant of active 2F3-scFv for GSH and GSSG
The binding constant of the active 2F3-scFv for GSH was assessed by the quenching of 2F3-scFv tryptophan fluorescence with GSH as described [26] . Refolded samples were adjusted to an A #)! of less than 0.05 in a final volume of 2 ml with buffer (0.1 M Tris\HCl, pH 7.5). Fluorescence was measured on a Hitachi 850 spectrofluorometer with excitation at 295 nm and emission at 333 nm. Samples were quenched with GSH, the concentration of which was gradually increased in a titration range. The binding constant of the active 2F3-scFv for GSSG was measured as described above.
Preparation of Se-2F3-scFv
The active 2F3-scFv proteins (0.1 mg) were dissolved in 1 ml of the solution containing 50 mM potassium phosphate, pH 7.0, and allowed to react with PMSF (4 µl of 0.2 mg\ml in acetonitrile) at 25 mC for 1 h. Nitrogen gas was bubbled into the mixture for 20 min, mixed with 10 µl of 1 M NaHSe solution prepared by the procedure of Klayman and Griffin [27] and then incubated at 40 mC for 36 h under a nitrogen atmosphere. The proteins were separated from the reaction mixture on a Sephadex G-25 column eluted with buffer (20 mM Tris\HCl, pH 8.0). The active fractions were pooled and finally freeze-dried.
Determination of the GPX activity of Se-2F3-scFv
The GPX activity of Se-2F3-scFv was assayed as described in [3] . The reaction was performed at 37 mC in 500 µl of a solution containing 50 mM potassium phosphate buffer, pH 7.0, 1 mM EDTA, 1 mM NaN $ , 1 mM GSH, 1 unit of GSH reductase and 10-50 nM Se-2F3-scFv. The mixture was preincubated for 7 min ; 0.25 mM NADPH solution was then added and incubated for 3 min at 37 mC. Thereafter the reaction was initiated by the addition of 0.5 mM H # O # . The activity was determined by the decrease in NADPH absorption at 340 nm. Appropriate controls were run without Se-2F3-scFv and subtracted. The activity unit of Se-2F3-scFv is defined as the amount of Se-2F3-scFv that uses 1 µmol of NADPH\min. Specific activity is expressed in units\µmol of Se-2F3-scFv.
RESULTS

Construction of expression vector
The genetic construct used to generate a 2F3-scFv from mice hybridomas immunized with a hapten, GSH-S-N # phBu (2F3), conjugated to BSA is shown in Scheme 2. The construct encodes the V H fragment of antibody 2F3 followed by a spacer (Gly % Ser) $ that links it to the C-terminus of the V L fragment. The linker consists of 15 residues and has commonly been used in constructing scFv protein from an antibody. In addition, the construct encodes a hexahistidine tag at the C-terminus of the V L fragment. The sequences of the V H and V L inserts are shown in Figure 2 . Repeated amplification, cloning and sequencing of V H and V L indicated that our sequence is correct and that there was no PCR error ( Figure 3 ).
Scheme 2 Protocol for the construction of the expression vector pTMFscFv encoding 2F3-scFv nucleotide sequences
Expression and partial purification of recombinant 2F3-scFv
Bacteria containing the encoding 2F3-scFv sequences in the pTMF vector produce a significant fraction of scFv (29.9 kDa) after induction with IPTG ( Figure 4A bacterial proteins respectively. Western blots of SDS\PAGE gels were probed with anti-His ' and then with peroxidase-conjugated goat anti-mouse IgG. As shown in Figure 4 (B), the anti-His ' cross-reacted with the recombinant 2F3-scFv in both inclusion bodies and total bacteria lysate, indicating that 2F3-scFv proteins were expressed in the bacteria. The 2F3-scFv proteins were partly purified by washing the bacterial pellet with a detergent solution, thus taking advantage of the insolubility of the protein in inclusion bodies. This procedure produced recombinant proteins that were at least 50 % pure ( Figure 4A ).
There are many previous examples of purification, by IMAC, of proteins with His tags expressed in E. coli [28] . These chromatographic steps all operated with buffers that kept the proteins in the denatured reduced state. The loaded samples were eluted with two different buffers ; samples containing the second of the two peaks were pooled.
Refolding of the recombinant 2F3-scFv in vitro
Inclusion bodies were solubilized in 8 M urea ; disulphide bonds were fully reduced. Starting with totally reduced and denatured material, mixed disulphide bonds were formed between the thiol groups of the protein and GSH ; the modified 2F3-scFv was allowed to gain its native conformation by gel filtration on an Ultrogel Ac4A4 column loaded with renaturation buffer containing 0.5 mM GSH and 0.1 mM GSSG, under conditions that allowed the reshuffling of S-S bonds. After refolding in itro, most of the recombinant protein migrated on SDS\PAGE more rapidly than the reduced protein ( Figure 4A) , showing that intramolecular disulphide bonds had formed [29] . The refolded native proteins were further purified with a Sephadex G-75 column.
Determination of the binding constant of 2F3-scFv and the GPX activity of Se-2F3-scFv
The fluorescence quench assay and the calculation of affinity were performed for 2F3-scFv. Values were calculated from Scatchard plots [22] as (2.46p0.21)i10& M −" and (1.03p0.14)i 10& M −" for GSH and GSSG respectively (meanspS.D.). The binding constants of intact antibody 2F3 were 2.91i10' M −" and 9.24i10& M −" for GSH and GSSG respectively.
Active serine residues in the antibody variable regions can be converted into selenocysteine residues by chemical mutation. Therefore the essential catalytic selenocysteine residues can also be incorporated into the GSH-binding site of active 2F3-scFv. The method for preparing Se-2F3-scFv was the same as that reported for preparing selenium-containing antibody enzyme [21, 22] . The GPX activity of the Se-2F3-scFv-catalysed reduction of H # O # by GSH was measured with a coupled test procedure assay [3] and found to be 3394 units\µmol, which approaches the GPX activity of native enzyme from rabbit liver.
DISCUSSION
Although some catalytic antibodies have been reported with efficiencies similar to that of the corresponding natural enzyme, in general it has been difficult to obtain a highly active catalyst [30] . We established a series of catalytic antibodies capable of catalysing the breakdown of H # O # by GSH with different haptens. A group of these catalytic antibodies exhibit high reactivity and substrate specificity for GSH, yet each individual antibody shows different kinetic parameters [25] . Most importantly, some of these catalytic antibodies have catalytic efficiencies that remarkably exceed that of the native enzyme (Table 1) .
In the present study we produced an scFv recombinant protein from 2F3 hybridoma cells. We choose this particular 2F3 antibody because its GPX activity was the highest. The restriction enzyme sites of encoding V L and V H sequences in pGEM-T vector were not suitable for the pTHA90 vector. PCR amplification was therefore performed to introduce restriction enzyme sites into the V L and V H sequences by using appropriate primers. The sequences that encoded V L and V H were subcloned into pTHA90 and linked with a linker (Gly % Ser) $ belonging to pTHA90. However, the quantity of 2F3-scFv proteins produced by the pTHA90 vector was small. The sequences that encoded (NH # ) # -V H -linker-V L -COOH were subcloned into pTMF expression vector, which uses the bacteriophage T7 RNA polymerase and the T7 promoter to drive protein synthesis. The T7 polymerase elongates polypeptide chains approx. 5-fold faster than the endogenous bacterial polymerase [31] . The rapid production of such material is the major advantage of using bacterial inclusion bodies to produce scFv. When the pTMF expression vector was transformed into the different bacterial strains JM109 (DE3), BL21 (DE3) and BL21 (coden plus), the amounts of scFv proteins produced were different. The differences perhaps relate to the genetic background and cytosolic environment of the strains.
The main problem that we encountered during the production of active 2F3-scFv was in the refolding process. The abundance of protein expression systems renders the efficient production of most proteins possible but high-level expression of the recombinant proteins often results in protein aggregation and the accumulation of inclusion bodies [29] . Although several methods, including dilution, dialysis, diafiltration, gel filtration and immobilization on a solid support, can be employed to remove or decrease the levels of excess denaturing and reducing agents, allowing proteins to renature, each method is effective for an individual inclusion body [32] . The inactive 2F3-scFv protein was refolded with the use of gel filtration but the refolding yield was very low. The 2F3-scFv was produced in bacteria as inclusion bodies and approx. 6-10 mg of protein from 1 litre of bacterial culture was obtained after refolding.
The binding activity of the active 2F3-scFv was lower than that of the intact 2F3 antibody. Bacterially produced 2F3-scFv fragment usually has a lower affinity than the native, intact antibody from which it is derived, presumably owing to incorrect folding [33, 34] . The binding constants of 2F3 antibody for GSH and GSSG were about 10-fold that of the active 2F3-scFv by fluorescence quench assay, indicating that 2F3-scFv retains the conformation of the variable regions of 2F3. The GPX activity of the Se-2F3-scFv-catalysed reduction of H # O # by GSH was 3394 units\µmol, which approaches that of the native enzyme from rabbit liver but was lower than that of the seleniumcontaining abzyme 2F3, which was 24 300 units\µmol. These results mean that pTMFscFv expression vector was correctly constructed and expressed in E. coli.
In conclusion, we have successfully constructed pTMFscFv expression vector. The 2F3-scFv protein produced by E. coli containing 2F3-scFv expression vector retains the binding and catalytic capabilities of the parent catalytic antibody. The expression of a catalytic antibody in single-chain form offers several advantages. The ability of the protein to be expressed in large amounts in E. coli may be advantageous for further largescale applications of catalytic antibodies and structural and biochemical studies. The smaller size and lower antigenicity of 2F3-scFv protein makes it have a great potential in the treatment of diseases mediated by oxidative stress.
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